Literature DB >> 20447502

Osteopenia and osteoporosis in epidermolysis bullosa.

Anna E Martinez1, Jemima E Mellerio.   

Abstract

Patients with the more severe forms of epidermolysis bullosa (EB) are at risk of developing osteopenia, osteoporosis and fractures. The cause is likely to be multifactorial and includes reduced mobility, a generally proinflammatory state, poor nutrition and hormonal factors. Monitoring this group with dual energy X-ray absorptiometry (DEXA) scans and plain radiographs is necessary to detect these changes. Data are lacking about the optimal approach to managing poor bone health in EB, although it seems that encouraging mobility, supplementation of calcium and vitamin D where necessary, with the addition of a bisphosphonate when there is evidence of fractures, may be helpful. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20447502     DOI: 10.1016/j.det.2010.01.006

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  5 in total

Review 1.  [Hereditary epidermolysis bullosa in school children and adolescents. Clinical picture and interdisciplinary management].

Authors:  H Ott; C Eich; K Schriek; B Ludwikowski
Journal:  Hautarzt       Date:  2016-04       Impact factor: 0.751

Review 2.  Novel and emerging therapies in the treatment of recessive dystrophic epidermolysis bullosa.

Authors:  Ellie Rashidghamat; John A McGrath
Journal:  Intractable Rare Dis Res       Date:  2017-02

3.  Nutritional outcomes in children with epidermolysis bullosa: the experiences of two centers in Korea.

Authors:  Kyu-Yeun Kim; Ran Namgung; Soon Min Lee; Soo Chan Kim; Ho Sun Eun; Min Soo Park; Kook In Park; Chul Lee
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

4.  Pain care for patients with epidermolysis bullosa: best care practice guidelines.

Authors:  Kenneth R Goldschneider; Julie Good; Emily Harrop; Christina Liossi; Anne Lynch-Jordan; Anna E Martinez; Lynne G Maxwell; Danette Stanko-Lopp
Journal:  BMC Med       Date:  2014-10-09       Impact factor: 8.775

5.  Prioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: where should research direct to? an example of priority setting partnership in very rare disorders.

Authors:  Paula Davila-Seijo; Angela Hernández-Martín; Evanina Morcillo-Makow; Raúl de Lucas; Esther Domínguez; Natividad Romero; Eva Monrós; Marta Feito; Luis Carretero; Bea Aranegui; Ignacio García-Doval
Journal:  Orphanet J Rare Dis       Date:  2013-04-22       Impact factor: 4.123

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.